July 07, 2018
Article
An Extraordinary Healer essay honoring KAITLYN WHITEWATER, B.S.N., RN [SAINT FRANCIS HOSPITAL, 7 WEST ONCOLOGY/BONE MARROW TRANSPLANT UNIT, TULSA, OKLAHOMA]
FDA Approves Inlexzo for Some With Non–Muscle Invasive Bladder Cancer
Lunsumio plus Polivy Associated With Responses in MCL
Standing Up to Cancer with Lynch Syndrome
Zidesamtinib Elicits Responses in ROS1-Positive NSCLC